JP2023504560A5 - - Google Patents

Info

Publication number
JP2023504560A5
JP2023504560A5 JP2022533605A JP2022533605A JP2023504560A5 JP 2023504560 A5 JP2023504560 A5 JP 2023504560A5 JP 2022533605 A JP2022533605 A JP 2022533605A JP 2022533605 A JP2022533605 A JP 2022533605A JP 2023504560 A5 JP2023504560 A5 JP 2023504560A5
Authority
JP
Japan
Prior art keywords
cell
kit
antigen
promoter
cell according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022533605A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023504560A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/062992 external-priority patent/WO2021113432A1/en
Publication of JP2023504560A publication Critical patent/JP2023504560A/ja
Publication of JP2023504560A5 publication Critical patent/JP2023504560A5/ja
Priority to JP2025165386A priority Critical patent/JP2026017553A/ja
Pending legal-status Critical Current

Links

JP2022533605A 2019-12-03 2020-12-03 ｃ－Ｋｉｔ変異を発現する細胞およびその使用 Pending JP2023504560A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025165386A JP2026017553A (ja) 2019-12-03 2025-10-01 ｃ－Ｋｉｔ変異を発現する細胞およびその使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962943032P 2019-12-03 2019-12-03
US62/943,032 2019-12-03
PCT/US2020/062992 WO2021113432A1 (en) 2019-12-03 2020-12-03 Cells expressing c-kit mutations and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025165386A Division JP2026017553A (ja) 2019-12-03 2025-10-01 ｃ－Ｋｉｔ変異を発現する細胞およびその使用

Publications (2)

Publication Number Publication Date
JP2023504560A JP2023504560A (ja) 2023-02-03
JP2023504560A5 true JP2023504560A5 (https=) 2023-12-04

Family

ID=76222653

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022533605A Pending JP2023504560A (ja) 2019-12-03 2020-12-03 ｃ－Ｋｉｔ変異を発現する細胞およびその使用
JP2025165386A Pending JP2026017553A (ja) 2019-12-03 2025-10-01 ｃ－Ｋｉｔ変異を発現する細胞およびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025165386A Pending JP2026017553A (ja) 2019-12-03 2025-10-01 ｃ－Ｋｉｔ変異を発現する細胞およびその使用

Country Status (8)

Country Link
US (1) US20230051518A1 (https=)
EP (1) EP4069730A4 (https=)
JP (2) JP2023504560A (https=)
CN (1) CN115210254A (https=)
AU (1) AU2020395175A1 (https=)
CA (1) CA3163872A1 (https=)
IL (1) IL293598A (https=)
WO (1) WO2021113432A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12419913B2 (en) 2019-02-08 2025-09-23 Dna Twopointo, Inc. Modification of CAR-T cells
EP4532693A1 (en) * 2022-05-25 2025-04-09 Albert Einstein College of Medicine Methods for producing red blood cells
WO2023248126A1 (en) * 2022-06-20 2023-12-28 Crispr Therapeutics Ag Chimeric antigen receptor specific to cd117
WO2025117266A2 (en) * 2023-11-27 2025-06-05 Albert Einstein College Of Medicine Method of producing self-renewing erythroid cells from human progenitor cells
CN118725143B (zh) * 2024-07-15 2025-12-02 上海交通大学医学院附属瑞金医院 靶向kit d816v突变衍生抗原的tcr及应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1427422A1 (en) * 2001-09-20 2004-06-16 AB Science Use of tyrosine kinase inhibitors for whitening human skin and treating melanocyte dysfunction associated diseases
EP2892930B1 (en) * 2012-09-07 2019-08-14 University Of Miami Fusion proteins for promoting an immune response, nucleic acids encoding same, and methods of making and use thereof
US10835525B2 (en) * 2012-09-26 2020-11-17 Arog Pharmaceuticals, Inc. Method of inhibiting mutant C-KIT
EP4166148B1 (en) * 2014-06-06 2026-02-18 Memorial Sloan-Kettering Cancer Center Mesothelin-targeted chimeric antigen receptors and uses thereof
AU2016274989A1 (en) * 2015-06-12 2017-11-02 Immunomedics, Inc. Disease therapy with chimeric antigen receptor (car) constructs and t cells (car-t) or nk cells (car-nk) expressing car constructs
US20190309307A1 (en) * 2016-09-14 2019-10-10 Benitec Biopharma Limited REAGENTS FOR PRODUCING T-CELLS WITH NON-FUNCTIONAL T-CELL RECEPTORS (TCRs) COMPOSITIONS COMPRISING SAME AND USE THEREOF
CN109251183A (zh) * 2017-07-13 2019-01-22 广东东阳光药业有限公司 取代脲衍生物的晶型及其在药物中的应用

Similar Documents

Publication Publication Date Title
JP2023504560A5 (https=)
JP2021513347A5 (https=)
JP7487112B2 (ja) Ｃｄ１９指向性キメラ抗原受容体および免疫療法におけるその使用
JP2023502503A5 (https=)
JP7590034B2 (ja) Ｎｋｇ２ａを標的にする抗体及びその使用
JP2022510207A5 (https=)
US20180371052A1 (en) Chimeric antigen receptors and enhancement of anti-tumor activity
EP4148125A1 (en) Engineered immune cell for allotransplantation
JP2021519061A5 (https=)
JP2022527405A5 (https=)
IL314563A (en) Non-HLA-restricted T-cell receptors and their uses
JP2019534246A5 (https=)
RU2015116901A (ru) Композиции и способы для имуннотерапии
JP2023514148A5 (https=)
JP2022543742A5 (https=)
JP2021502829A5 (https=)
AU2014225788A1 (en) Engager cells for immunotherapy
JP2023548829A5 (https=)
JP2023548467A5 (https=)
Dhodapkar et al. Hematologic malignancies: plasma cell disorders
JP2023504560A (ja) ｃ－Ｋｉｔ変異を発現する細胞およびその使用
JP2021502828A5 (https=)
KR20250030977A (ko) 키메라 어댑터 폴리펩티드를 포함하는 조성물 및 방법
Vo et al. Cellular immunotherapy in multiple myeloma
US20230293584A1 (en) Composition and method of use recombinant fusion protein to generate car-immune cells